JCR Pharmaceuticals Co (TSE:4552) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. JCR Pharmaceuticals Co's Free Cash Flow for the three months ended in Dec. 2023 was 円0 Mil. JCR Pharmaceuticals Co's Revenue for the three months ended in Dec. 2023 was 円9,446 Mil. Therefore, JCR Pharmaceuticals Co's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, JCR Pharmaceuticals Co's current FCF Yield % is 12.11%.

The historical rank and industry rank for JCR Pharmaceuticals Co's FCF Margin % or its related term are showing as below:

TSE:4552' s FCF Margin % Range Over the Past 10 Years
Min: -40.94 Med: 5.27 Max: 21.72
Current: 21.72

During the past 13 years, the highest FCF Margin % of JCR Pharmaceuticals Co was 21.72%. The lowest was -40.94%. And the median was 5.27%.

TSE:4552's FCF Margin % is ranked better than
92.31% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.12 vs TSE:4552: 21.72

JCR Pharmaceuticals Co FCF Margin % Historical Data

The historical data trend for JCR Pharmaceuticals Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co FCF Margin % Chart

JCR Pharmaceuticals Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

0.36

9.35

-4.15

-40.94

21.72

JCR Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of JCR Pharmaceuticals Co's FCF Margin %

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JCR Pharmaceuticals Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's FCF Margin % falls into.

JCR Pharmaceuticals Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

JCR Pharmaceuticals Co's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	9312	/	42871
	=	21.72 %

JCR Pharmaceuticals Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	9446
	=	0.00 %

JCR Pharmaceuticals Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

JCR Pharmaceuticals Co (TSE:4552) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

JCRRF:USA

Address

3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021

Website

http://www.jcrpharm.co.jp

JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines